QSAR Study of Methionine Aminopeptidase Inhibitors as Anti-cancer Agents Using MLR Approach

Ajeet^1,

¹Department of Pharmaceutical Chemistry, S. D. College of Pharmacy and Vocational Studies, Muzaffarnagar, India

Cite this paper:
Ajeet. QSAR Study of Methionine Aminopeptidase Inhibitors as Anti-cancer Agents Using MLR Approach. American Journal of Pharmacological Sciences. 2013; 1(5):80-83. doi: 10.12691/ajps-1-5-2

Abstract

Here Benzimidazole analogues have been used to correlate the inhibition activity with the Eccentric Connectivity index (ECI), Fragment Complexity (FC) and McGowan Volumes (MG) descriptors for studying the quantitative structure activity relationship (QSAR) against methionine aminopeptidases for the development and evaluation of anti-cancer agents. Correlation may be an adequate predictive model which can help to provide guidance in designing and subsequently yielding greatly specific compounds that may have reduced side effects and improved pharmacological activities. We have used Multiple Linear Regression (MLR) for developing QSAR model. For the validation of the developed QSAR model, statistical analysis such as cross validation test (LOO-CV), quality factor, fischers test, root mean square deviation (RMSD), variance, standard deviation etc.; have been performed and all the tests validated this QSAR model with fraction of variance r² = 0.8906 and LOO-CV q² = 0.8904.

Keywords:
QSAR Multiple Linear Regression benzimidazole analogues methionine aminopeptidases (MetAPs)

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Giglione, C., Vallon, O., Meinnel, T., “Control of protein life-span by N-terminal methionine excision,” EMBO J., 22. 13-23. 2003.
[2]	Lowther, W.T., Matthews, B.W., “Structure and function of the methionine aminopeptidases,” Biochim. Biophys. Acta., 1477. 157-167. 2000.
[3]	Arfin, S. M., Kendall, R. L., Hall, L., Weaver, L. H., Stewart, A. E., Matthews, B.W., Bradshaw, R.A. “Eukaryotic methionyl aminopeptidases: twoclasses of cobalt-dependent enzymes,” Proc. Natl. Acad. Sci., 92. 7714-7718. 1995.
[4]	Verma, R.P., Hansch, C., “QSAR modeling of taxane analogues against colon cancer,” Eur. J. Med. Chem., 45. 1470-1477. 2010.
[5]	Sardana, S., Madan, A.K., “Topological models for prediction of antihypertensive activity of substituted benzylimidazoles,” J. Mol. Struct. (Theochem), 638. 41-49. 2003.
[6]	Gregg, S., Eiso, A., Jan Schultz B., “Integration of fragment screening and library design,” Drug Discovery Today, 12(23/24). 1032-1039. 2007.
[7]	Michael, H., Abraham, Adam, Ibrahim, Andreas, M., Zissimos. “Determination of sets of solute descriptors from chromatographic measurements,” Journal of Chromatography, 1037. 29-47. 2004.
[8]	Zahra Garkani-Nejad, Fereshteh Saneie. “QSAR study of benzimidazole derivatives inhibition on escherichia coli methionine aminopeptidase,” Bull. Chem. Soc. Ethiop., 24(3): 317-325. 2010.
[9]	Yap, C.W., “PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints,” J. Comput. Chem., 32(7). 1466-1474. 2011.
[10]	Ajeet, Tripathi, L., Kumar P., “Designing of Novel 6(H)-1,3,4-Thiadiazine Derivatives as MMP12 Inhibitors: A MLR and Docking Approach,” American Journal of Pharmacological Sciences, 1(2). 29-34. 2013.
[11]	Ajeet, “QSAR Study of Benzimidazole Derivatives Against MetAPs Using MLR Approach”, International Journal of Pharmaceutical Archive, 1(2), 42-46, 2012.
[12]	Ajeet, “QSAR Modeling of Recombinant Human Stromelysin Inhibitors– MLR Approach”, International Journal of Advance Pharmaceutical & Biological Sciences, 2012, 2(2), 171-175.
[13]	Ajeet, “Prediction of Novel Arylpiperazinyls (Pyrrolidin-2-one Derivatives) as Antiarrhythmic Agents – QSAR Model Development”, International Journal of Pharmaceutical Archive, 1(1), 12-20, 2012.
[14]	Ajeet, “Prediction of 44 novel succinyl hydroxamates and their carboxylic analogues against MMP2– QSAR modeling”, Novel Science International Journal, Pharmaceutical Sciences, 1(11-12), 713-717, 2012.
[15]	Ajeet, “Development of QSAR model for studying sulfonamide derivatives against carbonic anhydrase using multiple linear regression with McGowan volume and AlogP as molecular descriptors”, Journal of Harmonized Research in Pharmacy, 2(1), 45-53, 2013.
[16]	Ajeet, “QSAR Modeling of Beta-Lactam Antibiotic Cephalosporin Against Transpeptidase Using MLR Method”, European journal of Bioinformatics, 1, 1-7, 2013.
[17]	Ajeet, Kumar P., Tripathi, L., Development of QSAR model for studying sulfonamide derivatives against carbonic anhydrase using multiple linear regression with McGowan volume and AlogP as molecular descriptors. Journal of Harmonized Research in Pharmacy, 2(1), 45-53, 2013.